Notable Labs, Ltd.
NTBL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | 3,775% | -97.2% | -69.1% | – |
| Cost of Goods Sold | $0 | $1 | $2 | $2 |
| Gross Profit | $0 | -$1 | -$1 | -$1 |
| % Margin | 36.5% | -14,425% | -468.8% | -72.2% |
| R&D Expenses | $5 | $8 | $11 | $18 |
| G&A Expenses | $10 | $5 | $6 | $0 |
| SG&A Expenses | $10 | $5 | $6 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$1 | $1 | $0 |
| Operating Expenses | $15 | $13 | $17 | $24 |
| Operating Income | -$15 | -$13 | -$17 | -$24 |
| % Margin | -4,728.1% | -161,550% | -5,934.7% | -2,655.4% |
| Other Income/Exp. Net | $3 | -$1 | $1 | $0 |
| Pre-Tax Income | -$11 | -$14 | -$16 | -$24 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11 | -$14 | -$16 | -$24 |
| % Margin | -3,633.5% | -180,087.5% | -5,632.3% | -2,627.4% |
| EPS | -5.03 | -6.5 | -0.22 | -0.48 |
| % Growth | 22.6% | -2,854.5% | 54.2% | – |
| EPS Diluted | -5.03 | -6.5 | -0.22 | -0.48 |
| Weighted Avg Shares Out | 2 | 2 | 73 | 51 |
| Weighted Avg Shares Out Dil | 2 | 2 | 73 | 51 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $1 | $1 |
| EBITDA | -$14 | -$13 | -$17 | -$23 |
| % Margin | -4,645.2% | -157,512.5% | -5,820.4% | -2,486.6% |